Biodistribution of liposomes and C3 fragments associated with liposomes: Evaluation of their relationship

International Journal of Pharmaceutics

Volumn 205, Issue 1-2, 2000, Pages 183-193

  Ishida, Tatsuhiro ^a   Kojima, Hiroko ^a   Harashima, Hideyoshi ^a   Kiwada, Hiroshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

C3; Cholesterol; Complement; Drug delivery system (DDS); Liposomes

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; DIMETHYL ETHER; LIPOSOME; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; CIRCULATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG METABOLISM; LIPID COMPOSITION; LIVER METABOLISM; MALE; MEAN RESIDENCE TIME; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMAL; CHOLESTEROL; COMPLEMENT 3C; COMPLEMENT ACTIVATION; HYPOGLYCEMIC AGENTS; INSULIN; LIPOSOMES; MALE; RATS; RATS, WISTAR;

EID: 0034665074     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00511-1     Document Type: Article

References (42)

1. Allen T.M., Hansen C.B. Pharmacokinetics of Stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta. 1068:1991;133-141.
2. Brown E.J. Complement receptors and phagocytosis. Curr. Opin. Immunol. 3:1991;76-82.
3. Chonn A., Semple S.C., Cullis P.R. Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biophys. Acta. 1070:1991;215-222.
4. Chonn A., Cullis P.R., Devine D.V. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146:1991;4234-4241.
5. Derksen J.T., Morselt H.W., Scherphof G.L. Processing of different liposomal markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim. Biophys. Acta. 931:1987;33-40.
6. Devine D.V., Wong K., Serrano K., Chonn A., Cullis P.R. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta. 1191:1994;43-51.
7. Dijkstra J., Van Galen W.J.M., Hulstaert C.E., Kalicharan D., Roerdink F.H., Scherphof G.L. Interaction of liposomes with Kupffer cells in vitro. Exp. Cell Res. 150:1984;161-176.
8. Dijkstra J., Van Galen W.J.M., Scherphof G.L. Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles. Biochim. Biophys. Acta. 813:1985;287-297.
9. Funato K., Yoda R., Kiwada H. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta. 1103:1992;198-204.
10. Harashima H., Kiwada H. Studies on the mechanism of uptake of liposomes using an isolated perfused liver system. J. Liposome Res. 6:1996;61-75.
11. Harashima H., Kiwada H. Liposomal targeting and drug delivery: kinetic consideration. Adv. Drug Deliv. Rev. 19:1996;425-444.
12. Harashima H., Sakata K., Funato K., Kiwada H. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 11:1994;402-406.
13. Harashima H., Huong T.M., Ishida T., Manabe Y., Matsuo H., Kiwada H. Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats. Pharm. Res. 13:1996;1704-1709.
14. Harashima H., Matsuo H., Kiwada H. Identification of proteins mediating clearance of liposomes using a liver perfusion system. Adv. Drug Deliv. Rev. 32:1998;61-79.
15. Hernandez-Caselles T., Villalain J., Gomez-Fernandez J.C. Influence of liposomes charge and composition on their interaction with human blood serum proteins. Mol. Cell. Biochem. 120:1993;119-126.
16. Hwang K.J. Liposome pharmacokinetics. Ostro M.J. Liposomes: from Biophysics to Therapeutics. 1987;109-156 Marcel Dekker, New York.
17. Ishida T., Funato K., Kojima S., Yoda R., Kiwada H. Enhancing effect of cholesterol on the elimination of liposomes from circulation is mediated by complement activation. Int. J. Pharm. 156:1997;27-37.
18. Kirby J., Gregoriadis G. Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers. Biochem. J. 199:1981;251-254.
19. Kiwada H., Miyajima Y., Kato Y. Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum. Chem. Pharm. Bull. 35:1987;1189-1195.
20. Kume Y., Maeda H., Harashima H., Kiwada H. Saturable, Non-Michaelis-Menten uptake of liposomes by reticuloendothelial system. J. Pharm. Pharmacol. 43:1991;162-166.
21. Liu D. Biological factors involved in the blood clearance of liposomes by liver. Adv. Drug Deliv. Rev. 24:1997;201-213.
22. Liu D., Hu Q.G., Song Y.K. Liposome clearance from blood: different animal species have different mechanisms. Biochim. Biophys. Acta. 124:1995;277-284.
23. Liu D., Song Y.K., Liu S. Antibody dependent, complement mediated liver uptake of liposomes containing GM1. Pharm. Res. 12:1995;1775-1780.
24. Liu F., Liu D. Serum independent liposome uptake by mouse liver. Biochim. Biophys. Acta. 127:1996;5-11.
25. Marjan J., Xie Z., Devine D. Liposome-induced activation of the classical complement pathway does not require immunoglobulin. Biochim. Biophys. Acta. 1192:1994;35-44.
26. Matsuo H., Funato K., Harashima H., Kiwada H. The complement- but not mannose receptor-mediated phagocytosis is involved in hepatic uptake of cetylmannoside-modified liposomes in situ. J. Drug. Target. 2:1994;141-146.
27. Moghimi S.M., Patel H.M. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett. 233:1988;143-147.
28. Nagayasu A., Uchiyama K., Nishida T., Yamagiwa Y., Kawai Y., Kiwada H. Is control of distribution of liposomes between tumors and bone marrow possible? Biochim. Biophys. Acta. 127(81):1996;29-34.
29. Okada N., Yasuda T., Tsumita T., Okada H. Activation of the alternative complement pathway of guinea-pig by liposomes incorporated with trinitrophenylated phosphatidylethanolamine. Immunology. 45:1982;115-124.
30. Oldfield E., Chapman D. Effects of cholesterol and cholesterol derivatives on hydrocarbon chain mobility in lipids. Biochem. Biophys. Res. Commun. 43:1971;610-616.
31. Panagi Z., Avgoustakis K., Evangelators G., Ithakissios D.S. Protein-induced CF release from liposomes in vitro and its correlation with the BLOOD/RES biodistribution of liposomes. Int. J. Pharm. 163:1998;103-114.
32. Pangburn M.K. Activation of complement via the alternative pathway. Fed. Proc. 42:1983;139-143.
33. Patel H.M. Serum opsonins and liposomes: their interaction and opsonophagocytosis. CRC Crit. Rev. Ther. Drug Carrier Syst. 9:1992;39-90.
34. Pidgeon C., Hunt A. Calculating number and surface area of liposomes in any suspension. J. Pharm. Sci. 70:1981;173-176.
35. Pool G.L., French M.E., Edwards R.A., Huang L., Lumb R.H. Use of radiolabelled hexadecyl cholesterol ether as a liposome marker. Lipids. 17:1982;445-452.
36. Porter P.R., Reid K.B.M. Activation of the complement system by antibody-antigen complex: the classical pathway. Adv. Prot. Chem. 33:1979;1-71.
37. Senior J.H. Fate and behaviour of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193.
38. Senior J., Gregoriadis G. Stability of small unilamellar liposomes in serum and clearance from the circulation. Life Sci. 30:1982;2123-2136.
39. Szebeni J., Wassef N.M., Spielberg H., Rudolph A.S., Alving C.R. Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: Evidence for anti-lipid antibodies and alternative pathway activation. Biochem. Biophys. Res. Commun. 205:1994;255-263.
40. Tomlinson S. Complement defense mechanism. Curr. Opin. Immunol. 5:1993;83-89.
41. Wright S.D. Receptors for complement and the biology of phagocytosis. Gallin J.I., Goldstein I.M., Synderman R. Inflammation: Basic Principles and Clinical Correlates. 1992;477-495 Raven Press, New York.
42. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4:1981;879-890.